Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report

Clozapine is an antipsychotic drug for the treatment-resistant schizophrenia. Although clozapine is superior to other antipsychotics, it is less common in psychiatric prescriptions due to clozaphobia. Little is known about the use of clozapine during pregnancy and lactation, or its effect on the mot...

Full description

Bibliographic Details
Main Authors: Ömer Faruk Uygur, Hilal Uygur
Format: Article
Language:English
Published: AVES 2019-10-01
Series:Psychiatry and Clinical Psychopharmacology
Subjects:
Online Access:http://dx.doi.org/10.1080/24750573.2019.1627695
_version_ 1797914368595197952
author Ömer Faruk Uygur
Hilal Uygur
author_facet Ömer Faruk Uygur
Hilal Uygur
author_sort Ömer Faruk Uygur
collection DOAJ
description Clozapine is an antipsychotic drug for the treatment-resistant schizophrenia. Although clozapine is superior to other antipsychotics, it is less common in psychiatric prescriptions due to clozaphobia. Little is known about the use of clozapine during pregnancy and lactation, or its effect on the mother, foetus and baby. Pregnancy category of clozapine is considered to be of relatively reliable category B, while it is recommended to be avoided during breastfeeding. Switching from clozapine to other antipsychotics during breastfeeding may lead to psychotic exacerbations. In this case, low dose of clozapine may need to be added to the antipsychotic treatment initiated during breastfeeding. However, data on the safety of combination antipsychotics during breastfeeding are limited. Psychiatrists, obstetricians and pediatricians should closely monitor with team spirit on such cases, thus drug exposure and side effects of infant are minimized while the mother’s mental health is maintained. We aimed to present the growth and neurodevelopmental outcomes of infant exposed to clozapine during pregnancy and exposed to clozapine plus olanzapine during the lactation period.
first_indexed 2024-04-10T12:25:46Z
format Article
id doaj.art-9a55f4cdea094c1c8aa42eaa652b181b
institution Directory Open Access Journal
issn 2475-0581
language English
last_indexed 2024-04-10T12:25:46Z
publishDate 2019-10-01
publisher AVES
record_format Article
series Psychiatry and Clinical Psychopharmacology
spelling doaj.art-9a55f4cdea094c1c8aa42eaa652b181b2023-02-15T16:15:13ZengAVESPsychiatry and Clinical Psychopharmacology2475-05812019-10-0129474474710.1080/24750573.2019.16276951627695Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case reportÖmer Faruk Uygur0Hilal Uygur1Necip Fazil City HospitalNecip Fazil City HospitalClozapine is an antipsychotic drug for the treatment-resistant schizophrenia. Although clozapine is superior to other antipsychotics, it is less common in psychiatric prescriptions due to clozaphobia. Little is known about the use of clozapine during pregnancy and lactation, or its effect on the mother, foetus and baby. Pregnancy category of clozapine is considered to be of relatively reliable category B, while it is recommended to be avoided during breastfeeding. Switching from clozapine to other antipsychotics during breastfeeding may lead to psychotic exacerbations. In this case, low dose of clozapine may need to be added to the antipsychotic treatment initiated during breastfeeding. However, data on the safety of combination antipsychotics during breastfeeding are limited. Psychiatrists, obstetricians and pediatricians should closely monitor with team spirit on such cases, thus drug exposure and side effects of infant are minimized while the mother’s mental health is maintained. We aimed to present the growth and neurodevelopmental outcomes of infant exposed to clozapine during pregnancy and exposed to clozapine plus olanzapine during the lactation period.http://dx.doi.org/10.1080/24750573.2019.1627695clozapineolanzapinebreastfeedingpregnancyneurodevelopmentalgrowthclozaphobia
spellingShingle Ömer Faruk Uygur
Hilal Uygur
Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report
Psychiatry and Clinical Psychopharmacology
clozapine
olanzapine
breastfeeding
pregnancy
neurodevelopmental
growth
clozaphobia
title Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report
title_full Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report
title_fullStr Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report
title_full_unstemmed Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report
title_short Neurodevelopmental and growth follow-up of the baby exposed to antipsychotics during pregnancy and lactation: a case report
title_sort neurodevelopmental and growth follow up of the baby exposed to antipsychotics during pregnancy and lactation a case report
topic clozapine
olanzapine
breastfeeding
pregnancy
neurodevelopmental
growth
clozaphobia
url http://dx.doi.org/10.1080/24750573.2019.1627695
work_keys_str_mv AT omerfarukuygur neurodevelopmentalandgrowthfollowupofthebabyexposedtoantipsychoticsduringpregnancyandlactationacasereport
AT hilaluygur neurodevelopmentalandgrowthfollowupofthebabyexposedtoantipsychoticsduringpregnancyandlactationacasereport